Menin and BCL2 inhibitors– shaken and stirred

Key Points

• To examine the role of menin and BCL2 inhibitors in cancer treatment and their interactions.
• Analysis of menin and BCL2 inhibitor effects on cancer cell lines
• Evaluation of apoptosis pathways triggered by these inhibitors
• Review of existing literature on signaling pathways related to menin and BCL2
• Menin and BCL2 inhibitors showed a significant reduction in cancer cell viability
• Increased apoptosis observed in treated cell lines
• Potential for combined therapeutic strategies highlighted